Evidence map›Paper›PMID 36430960›Full record

ReviewInternational journal of molecular sciences2022

The Four Homeostasis Knights: In Balance upon Post-Translational Modifications.

Stefania Pieroni, Marilena Castelli, Danilo Piobbico, Simona Ferracchiato, Damiano Scopetti, Nicola Di-Iacovo, Maria Agnese Della-Fazia, Giuseppe Servillo

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. TheCells · 2026
    Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Stefania PieroniDepartment of Medicine and Surgery, University of Perugia, Piazzale L. Severi 1, 06129 Perugia, Italy.ORCID 0000-0003-3910-503X
Marilena CastelliDepartment of Medicine and Surgery, University of Perugia, Piazzale L. Severi 1, 06129 Perugia, Italy.
Danilo PiobbicoDepartment of Medicine and Surgery, University of Perugia, Piazzale L. Severi 1, 06129 Perugia, Italy.
Simona FerracchiatoDepartment of Medicine and Surgery, University of Perugia, Piazzale L. Severi 1, 06129 Perugia, Italy.
Damiano ScopettiDepartment of Medicine and Surgery, University of Perugia, Piazzale L. Severi 1, 06129 Perugia, Italy.ORCID 0000-0003-3239-2398
Nicola Di-IacovoDepartment of Medicine and Surgery, University of Perugia, Piazzale L. Severi 1, 06129 Perugia, Italy.ORCID 0000-0001-5980-8854
Maria Agnese Della-FaziaDepartment of Medicine and Surgery, University of Perugia, Piazzale L. Severi 1, 06129 Perugia, Italy.ORCID 0000-0002-5373-8477
Giuseppe ServilloDepartment of Medicine and Surgery, University of Perugia, Piazzale L. Severi 1, 06129 Perugia, Italy.ORCID 0000-0001-7960-7689
University of Perugia · IT

Funding

Associazione Umbra Contro il Cancro 2021Fondazione Ricerca Oncologica Menesini (FROM) 2022
6 · The paper itself

Abstract

A cancer outcome is a multifactorial event that comes from both exogenous injuries and an endogenous predisposing background. The healthy state is guaranteed by the fine-tuning of genes controlling cell proliferation, differentiation, and development, whose alteration induces cellular behavioral changes finally leading to cancer. The function of proteins in cells and tissues is controlled at both the transcriptional and translational level, and the mechanism allowing them to carry out their functions is not only a matter of level. A major challenge to the cell is to guarantee that proteins are made, folded, assembled and delivered to function properly, like and even more than other proteins when referring to oncogenes and onco-suppressors products. Over genetic, epigenetic, transcriptional, and translational control, protein synthesis depends on additional steps of regulation. Post-translational modifications are reversible and dynamic processes that allow the cell to rapidly modulate protein amounts and function. Among them, ubiquitination and ubiquitin-like modifications modulate the stability and control the activity of most of the proteins that manage cell cycle, immune responses, apoptosis, and senescence. The crosstalk between ubiquitination and ubiquitin-like modifications and post-translational modifications is a keystone to quickly update the activation state of many proteins responsible for the orchestration of cell metabolism. In this light, the correct activity of post-translational machinery is essential to prevent the development of cancer. Here we summarize the main post-translational modifications engaged in controlling the activity of the principal oncogenes and tumor suppressors genes involved in the development of most human cancers.

Indexed as

Protein Processing, Post-TranslationalUbiquitinHomeostasisHumansProteinsUbiquitinationProteinsUbiquitinMYConcogenesonco-suppressorsp53post-translational modificationsRASRBubiquitin and ubiquitin-like proteins

Identifiers

PMID36430960
PMCPMC9696182
OpenAlexW4309717838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.